Turkey vs United Kingdom of Great Britain and Northern Ireland: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Turkey
0.0%
in 2024
United Kingdom of Great Britain and Northern Ireland
0.0%
in 2024
Turkey rank
167th
United Kingdom of Great Britain and Northern Ireland rank
167th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Turkey
- United Kingdom of Great Britain and Northern Ireland
How they compare
Turkey currently reports 0.0% against 0.0% in United Kingdom of Great Britain and Northern Ireland, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was United Kingdom of Great Britain and Northern Ireland ahead.
Turkey ranks 167th and United Kingdom of Great Britain and Northern Ireland ranks 167th of 246 countries.
Turkey has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Turkey | United Kingdom of Great Britain and Northern Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | Turkey |
| 2020s | 0.1% | 0.0% | 0.1% | Turkey |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Turkey or United Kingdom of Great Britain and Northern Ireland?
- Turkey, at 0.0% against 0.0% in United Kingdom of Great Britain and Northern Ireland as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Turkey and United Kingdom of Great Britain and Northern Ireland?
- 0.0%, with Turkey ahead.
- How many years of comparable data are there for Turkey and United Kingdom of Great Britain and Northern Ireland?
- 10 years are reported by both, from 2015 to 2024.
- How do Turkey and United Kingdom of Great Britain and Northern Ireland rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Turkey ranks 167th and United Kingdom of Great Britain and Northern Ireland ranks 167th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.